SAF
TDOC icon

Smith Anglin Financial’s Teladoc Health TDOC Stock Holding History

Smith Anglin Financial’s Portfolio TDOC Stock Details TDOC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-11,898
Closed -$108K – 229
2024
Q4 		$108K Buy
+11,898
New +$115K 0.01% 207

Other funds holding TDOC

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
MRCP
Maple Rock Capital Partners Toronto, Ontario, Canada $3.07B AUM 157.2% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Smith Anglin Financial's TDOC Position: Q1 2025 in Review

Smith Anglin Financial sold out of Teladoc Health (TDOC) in Q1 2025, closing a stake of 11,898 shares — an estimated $108K sold.

Smith Anglin Financial first reported a position in TDOC in Q4 2024 and held it in 1 quarter. The position peaked at $108K in Q4 2024. 383 funds tracked by Wall St. Rank hold TDOC as of Q1 2025.

  • Smith Anglin Financial reported no remaining Teladoc Health position as of Q1 2025 after selling out during the quarter.
  • Smith Anglin Financial sold 11,898 Teladoc Health shares in Q1 2025, an estimated $108K.
  • Smith Anglin Financial first reported a position in Teladoc Health in Q4 2024 and held it in 1 quarter.
  • Smith Anglin Financial's Teladoc Health position peaked at $108K in Q4 2024.
  • 383 funds tracked by Wall St. Rank held Teladoc Health as of Q1 2025.

Based on Smith Anglin Financial's 13F filing for Q1 2025, filed 10 Apr 2025.